Back

Auditing the safety and efficacy of interventional septal reduction therapies in hypertrophic obstructive cardiomyopathy at a specialized tertiary centre

18 April 2023 (10:55 - 11:55)
Organised by:
Congress Presentation Part of: Ventricular Arrhythmias and SCD - Round 5 - Others Congenital Heart Disease and Paediatric Cardiology, Other EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Michela Sorbini

Royal Brompton and Harefield NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Cardiogenetics and Artificial Intelligence: the Mutscore Algorithm
Doctor A. Porretta (Paris, FR)
Abstract Slides
Presentation thumbnail
Optimization of the clinical workflow and patient pathway in cardiac monitor implantation and follow-up
Doctor V. Vanhala (Tampere, FI)
Abstract Slides
Presentation thumbnail
Mortality and ventricular arrhythmias in patients with atrial fibrillation on sotalol
Doctor H. Lenhoff (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Implementation and first outcomes of a novel SOP for preprocedural transesophageal echocardiography screening in course of atrial arrhythmia ablation
Mr S. Dittrich (Cologne, DE)
Abstract Slides
Presentation thumbnail
Multi-modal physiological parameter for mapping ablation lesions
Mr S. Masse (Toronto, CA)
Abstract Slides

Access the full session

Session thumbnail
Ventricular Arrhythmias and SCD - Round 5 - Others

The Event

Event poster

EHRA 2023

18 April 2023 10:55 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources